319 related articles for article (PubMed ID: 17898703)
21. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.
Saiz-Rodríguez M; Ochoa D; Herrador C; Belmonte C; Román M; Alday E; Koller D; Zubiaur P; Mejía G; Hernández-Martínez M; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):321-329. PubMed ID: 30281924
[TBL] [Abstract][Full Text] [Related]
23. OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
Hajj A; Halepian L; Osta NE; Chahine G; Kattan J; Rabbaa Khabbaz L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346387
[TBL] [Abstract][Full Text] [Related]
24. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.
De Gregori M; Garbin G; De Gregori S; Minella CE; Bugada D; Lisa A; Govoni S; Regazzi M; Allegri M; Ranzani GN
Eur J Clin Pharmacol; 2013 Sep; 69(9):1651-8. PubMed ID: 23686330
[TBL] [Abstract][Full Text] [Related]
25. Influence of mu-opioid receptor variant on morphine use and self-rated pain following abdominal hysterectomy.
Sia AT; Lim Y; Lim EC; Ocampo CE; Lim WY; Cheong P; Tan EC
J Pain; 2013 Oct; 14(10):1045-52. PubMed ID: 23726045
[TBL] [Abstract][Full Text] [Related]
26. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
27. Molecular Basis of Cancer Pain Management: An Updated Review.
V Subramaniam A; Salem Yehya AH; Oon CE
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31547335
[TBL] [Abstract][Full Text] [Related]
28.
Firfirey F; September AV; Shamley D
Pharmacogenomics; 2022 Jun; 23(9):513-530. PubMed ID: 35727214
[No Abstract] [Full Text] [Related]
29. Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.
Issac MS; El-Nahid MS; Wissa MY
Mol Diagn Ther; 2014 Feb; 18(1):73-83. PubMed ID: 24092646
[TBL] [Abstract][Full Text] [Related]
30. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
31. OPRM1 and ABCB1 polymorphisms and their effect on postoperative pain relief with piritramide.
Bartošová O; Polanecký O; Perlík F; Adámek S; Slanař O
Physiol Res; 2015; 64(Suppl 4):S521-7. PubMed ID: 26681082
[TBL] [Abstract][Full Text] [Related]
32. Human Genetic Variability Contributes to Postoperative Morphine Consumption.
De Gregori M; Diatchenko L; Ingelmo PM; Napolioni V; Klepstad P; Belfer I; Molinaro V; Garbin G; Ranzani GN; Alberio G; Normanno M; Lovisari F; Somaini M; Govoni S; Mura E; Bugada D; Niebel T; Zorzetto M; De Gregori S; Molinaro M; Fanelli G; Allegri M
J Pain; 2016 May; 17(5):628-36. PubMed ID: 26902643
[TBL] [Abstract][Full Text] [Related]
33. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
34. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
35. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Brown MS; Paul J; Harvey-Wilkes K; Terrin N; Huggins GS; Aranda JV; Davis JM
JAMA; 2013 May; 309(17):1821-7. PubMed ID: 23632726
[TBL] [Abstract][Full Text] [Related]
36. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
37. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
38. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.
Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J
Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916
[TBL] [Abstract][Full Text] [Related]
39. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
40. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
